Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 2
2004 1
2006 1
2008 1
2011 2
2012 2
2013 1
2018 3
2019 1
2020 1
2021 1
2022 3
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators. Galimberti V, et al. Among authors: sargenti m. Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Lancet Oncol. 2013. PMID: 23491275 Free PMC article. Clinical Trial.
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
A narrative review for radiation oncologists to implement preoperative partial breast irradiation.
Zerella MA, Zaffaroni M, Ronci G, Dicuonzo S, Rojas DP, Morra A, Gerardi MA, Fodor C, Rondi E, Vigorito S, Penco S, Sargenti M, Baratella P, Vicini E, Morigi C, Kahler-Ribeiro-Fontana S, Galimberti VE, Gandini S, De Camilli E, Renne G, Cattani F, Veronesi P, Orecchia R, Jereczek-Fossa BA, Leonardi MC. Zerella MA, et al. Among authors: sargenti m. Radiol Med. 2023 Dec;128(12):1553-1570. doi: 10.1007/s11547-023-01706-6. Epub 2023 Aug 31. Radiol Med. 2023. PMID: 37650981 Review.
[Nutritional therapy in surgical patients: an update].
Gianotti L, Nespoli L, Sargenti M, Nespoli A. Gianotti L, et al. Among authors: sargenti m. Minerva Anestesiol. 2003 Apr;69(4):275-80. Minerva Anestesiol. 2003. PMID: 12766719 Free article. Review. Italian.
BRCA1/2 germline missense mutations: a systematic review.
Corso G, Feroce I, Intra M, Toesca A, Magnoni F, Sargenti M, Naninato P, Caldarella P, Pagani G, Vento A, Veronesi P, Bonanni B, Galimberti V. Corso G, et al. Among authors: sargenti m. Eur J Cancer Prev. 2018 May;27(3):279-286. doi: 10.1097/CEJ.0000000000000337. Eur J Cancer Prev. 2018. PMID: 28277317
Male breast cancer: a multicenter study to provide a guide for proper management.
Lissidini G, Nicosia L, Sargenti M, Cucchi MC, Fabi A, Falco G, Gardani M, Grilz G, Maugeri I, Murgo R, Neri A, Pellini F, Sensi C, Scomersi S, Taffurelli M, Bagnardi V, Oriecuia C, Pagan E, Sangalli C, Dessena M, Veronesi P, Galimberti V. Lissidini G, et al. Among authors: sargenti m. Breast Cancer Res Treat. 2024 Nov;208(1):29-40. doi: 10.1007/s10549-024-07380-0. Epub 2024 Jun 19. Breast Cancer Res Treat. 2024. PMID: 38896332
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center.
Nicosia L, Lissidini G, Sargenti M, Bozzini AC, Farante G, Vila J, Oriecuia C, Pagan E, Bagnardi V, Lazzeroni M, Pesapane F, Sangalli C, Galimberti V, Cassano E, Veronesi P. Nicosia L, et al. Among authors: sargenti m. Breast Cancer Res Treat. 2022 Nov;196(2):371-377. doi: 10.1007/s10549-022-06689-y. Epub 2022 Sep 17. Breast Cancer Res Treat. 2022. PMID: 36114939 Free PMC article.
21 results